P
CVS icon

&Partners’s CVS Health CVS Stock Holding History

&Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
154,954
+13,240
+9% +$1.02M 0.06% 298
2025
Q4 		$11.2M Buy
141,714
+17,548
+14% +$1.38M 0.06% 282
2025
Q3 		$9.36M Sell
124,166
-4,092
-3% -$280K 0.06% 278
2025
Q2 		$8.84M Buy
128,258
+27,647
+27% +$1.81M 0.07% 253
2025
Q1 		$6.76M Buy
100,611
+14,992
+18% +$897K 0.07% 244
2024
Q4 		$3.92M Buy
85,619
+41,897
+96% +$2.35M 0.05% 320
2024
Q3 		$2.75M Buy
43,722
+28,762
+192% +$1.68M 0.05% 306
2024
Q2 		$884K Buy
14,960
+9,571
+178% +$599K 0.04% 383
2024
Q1 		$430K Buy
+5,389
New +$412K 0.06% 298
2023
Q1 		– Sell
-2,174
Closed -$203K – 185
2022
Q4 		$203K Sell
2,174
-435
-17% -$42K 0.1% 166
2022
Q3 		$249K Sell
2,609
-232
-8% -$23K 0.14% 140
2022
Q2 		$263K Buy
2,841
+576
+25% +$56.2K 0.15% 138
2022
Q1 		$229K Buy
2,265
+100
+5% +$10.5K 0.13% 166
2021
Q4 		$223K Sell
2,165
-259
-11% -$23.9K 0.13% 162
2021
Q3 		$206K Hold
2,424
– – 0.13% 170
2021
Q2 		$202K Buy
+2,424
New +$199K 0.13% 171

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

&Partners's CVS Position: Q1 2026 in Review

&Partners increased its CVS Health (CVS) stake by 9.3% in Q1 2026, buying an estimated $1.02M and bringing the position to 154,954 shares worth $11.1M. The position accounts for 0.06% of the portfolio, ranked #298.

&Partners first reported a position in CVS in Q2 2021 and has held it in 16 quarters since. The position peaked at $11.2M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • &Partners held 154,954 shares of CVS Health worth $11.1M as of Q1 2026.
  • &Partners bought 13,240 CVS Health shares in Q1 2026, an estimated $1.02M.
  • CVS Health made up 0.06% of &Partners's portfolio in Q1 2026, its #298 holding.
  • &Partners first reported a position in CVS Health in Q2 2021 and has held it in 16 quarters since.
  • &Partners's CVS Health position peaked at $11.2M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.